Nephrotic Syndrome
Nephrotic syndrome is a kidney disorder that causes your body to excrete too much protein in your urine, leading to symptoms like swelling, especially in the legs and around the eyes, and increased cholesterol levels.
Nephrotic Syndrome: Rituximab Treatment Comparison
We are comparing two Rituximab treatment plans for adults with relapsing nephrotic syndrome. The goal is to find out which regimen better prevents relapses and improves quality of life.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you at least 18 years old?
- Do you have a history of nephrotic syndrome (swelling, high protein in urine) that has come back at least once?
- Are you currently taking any immunosuppressive medications to keep your condition stable?
- Are you pregnant or breastfeeding?
- Have you had any major infections or severe health issues in the last 6 months?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Szpital Uniwersytecki Nr 1 Im. Dr. A. Jurasza W Bydgoszczy
Klinika Nefrologii, Nadciśnienia Tętniczego i Chorób Wewnętrznych
Bydgoszcz, Poland
Samodzielny Publiczny Szpital Kliniczny Im.Andrzeja Mieleckiego Slaskiego Uniwersytetu Medycznego W Katowicach
Katedra i Klinika Nefrologii, Transplantologii i Chorób Wewnętrznych
Katowice, Poland
Wojewodzki Szpital Zespolony W Kielcach SPZOZ
Kliniczny Oddział Nefrologii i Transplantologii Nerek
Kielce, Poland
Sponsor: Medical University Of Lodz
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.